M Klemsz

Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.

Scott R. McKercher, Bruce E. Torbett, Kenton L. Anderson et al. · The EMBO Journal · 1996 · 1.1K citations · Full text

Laboratory Hematology, Multiple Hematopoietic Abnormalities, Genetic Disorder +10

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.

Win May, Stephen L. Lessnick, Benjamin S. Braun et al. · Molecular and Cellular Biology · 1993 · 498 citations · Full text

Potent Transcriptional Activator, Transcriptional Regulation, Systems Biology +10

PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Jagan M.R. Pongubala, Sujatha Nagulapalli, M Klemsz et al. · Molecular and Cellular Biology · 1992 · 356 citations · Full text

Molecular Regulation, Immunoglobulin Kappa 3, Immunology +20

Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation

J. Pongubala, Charles Van Beveren, Sujatha Nagulapalli et al. · Science · 1993 · 278 citations

Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1

Robert Hromas, Attilio Orazi, RS Neiman et al. · Blood · 1993 · 210 citations · Full text